TPG, a United States-based private equity investment firm, has completed the acquisition of Optum UK from UnitedHealth Group in a transaction valued at approximately $400m (£300m). The company operates EMIS, a software platform whose systems are utilized by more than half of general practices throughout England, making it responsible for managing electronic health records belonging to millions of patients across the National Health Service.
The transaction has generated significant concern among medical professionals, lawmakers, campaign organizations, and human rights advocates who contend that the transfer occurred with insufficient public transparency. The Doctors’ Association UK released a statement expressing alarm that private equity interests have acquired control over critical infrastructure used in primary care, noting that the business model prioritizes investor returns rather than patient welfare. Helen Morgan, the Liberal Democrats’ health spokesperson, characterized such arrangements as receiving approval without adequate scrutiny or patient protections, calling for the government to support British technology alternatives instead.
Critics have also highlighted TPG’s international healthcare operations as grounds for concern. Earlier this year, an investigation by the International Consortium of Investigative Journalists examined hospitals in Kenya operated by Evercare, a healthcare organization backed by TPG’s Rise Fund. The investigation documented allegations that certain patients accumulated substantial medical debt, with some reportedly required to pledge land deeds as security for unpaid medical expenses. TPG disputed these characterizations, stating it has invested more than $100m in Evercare over six years, resulting in improvements in quality, accessibility, and patient rights policies.
Anna Marriott, formerly a health policy official at Oxfam, stated the acquisition should generate significant apprehension, asserting that private equity involvement in healthcare has accelerated faster than regulatory protections have developed. Both EMIS and TPG have issued statements emphasizing their commitment to data protection standards and asserting that the ownership change has not altered how patient information is stored, protected, or governed. EMIS noted that the acquisition received government review under the National Security and Investment Act 2021. The Department of Health and Social Care declined to comment on the matter.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI